All articles tagged with #skin cancer
Dermatologists say the number-one sign of all common skin cancers—basal cell, squamous cell, and melanoma—is a change in an existing spot or the appearance of new skin lesions; prompt evaluation is crucial, as early detection greatly improves outcomes, with melanoma survival over 99% when diagnosed before it spreads beyond the skin.
Dermatologists say the number-one sign of skin cancer—across all types—is a change in a spot on the skin, such as growth, bleeding, itching, tenderness, or a new lesion. Early detection is crucial: treating basal and squamous cell cancers is highly effective when found early, and melanoma has a survival rate over 99% when confined to the skin, highlighting the importance of monitoring skin changes and seeking evaluation promptly.
The FDA withdrew its 2015 proposed rule that would have barred anyone under 18 from using tanning beds, leaving regulations to state laws that already restrict or permit teen use. The withdrawal followed more than 8,100 public comments, with concerns about compliance burdens and personal choice, while authorities emphasize that UV exposure raises skin cancer risk and that sunlamps still warrant caution and potential future regulatory action.
An oncologist aged 50+ urges people over 50 to routinely screen for skin cancer, stressing that it’s the most common cancer and is highly treatable when detected early. Screenings combine self-exams and professional skin checks, with risk assessments (such as the American Cancer Society’s CancerRisk360) guiding personalized screening plans. He also emphasizes not skipping other essential screenings for those 50+, including colorectal cancer (colonoscopy every 10 years starting at 45 or earlier for higher risk) and lung cancer (annual low‑dose CT for high‑risk individuals), underscoring the importance of following up on any concerning findings.
Scientists have discovered that sunburn damages a protective protein called YTHDF2 in skin cells, leading to uncontrolled inflammation that can trigger skin cancer. The research highlights how UV exposure breaks down YTHDF2, allowing non-coding RNAs to activate immune pathways associated with cancer development, offering new avenues for prevention and treatment.
A study shows that tanning beds significantly increase the risk of melanoma and cause more skin mutations, especially in younger users, challenging the myth that tanning beds are safe.
A Tel Aviv University study reveals that melanoma cells release extracellular vesicles that disable immune cells, providing new insights that could lead to improved treatments for skin cancer.
A new study finds that tanning beds cause DNA damage across nearly the entire skin surface, significantly increasing melanoma risk, with users showing almost twice as many mutations as non-users, prompting calls for stricter regulations and warnings.
A recent study shows that tanning beds cause widespread DNA mutations across nearly the entire skin surface, significantly increasing the risk of melanoma, with indoor tanners having nearly three times the risk compared to non-users. The research highlights the dangers of indoor tanning, especially among young people, and calls for stricter regulations similar to those for other carcinogens like tobacco.
A new study shows that tanning beds significantly increase melanoma risk, causing widespread DNA mutations across the skin, even in areas not exposed to sunlight, challenging industry claims of safety and highlighting the need for stricter regulations and public awareness.
Humans can develop horn-like growths called cutaneous horns, which are keratin masses that often develop from skin lesions, some benign and others malignant, and are influenced by factors like sun exposure and age. These horns can grow to large sizes and require medical attention, with treatment typically involving surgical removal.
Phio Pharmaceuticals reports positive pathology results from its Phase 1b trial of the cancer therapeutic INTASYL PH-762, showing high tumor clearance rates and a favorable safety profile, indicating potential as a non-surgical treatment for skin cancers.
A large study using VA data shows that nicotinamide, a form of vitamin B3, can significantly reduce the risk of skin cancer, especially when taken early after the first diagnosis, with a 14% overall risk reduction and up to 54% for initial cases, suggesting a potential shift in prevention strategies.
The anti-sunscreen movement questions the safety of chemical ingredients and their absorption into the bloodstream, but evidence still supports sunscreen use for skin cancer prevention. While sunlight has benefits like vitamin D production, overexposure increases skin cancer risk, especially for lighter skin tones. Public health guidelines suggest balancing sun exposure with protection, considering individual risk factors, and recognizing the benefits of moderate sunlight.
A large-scale study involving over 33,000 patients found that nicotinamide, a vitamin B3 supplement, can reduce the risk of skin cancer recurrence by up to 54%, especially when taken after a first skin cancer diagnosis, suggesting it could be used earlier in prevention strategies.